alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.2

                                  CERTIFICATION

I, Payesh Jhaveri, certify that:

1. I have reviewed this Form 10-KSB of LMIC, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;

b. Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

c. Disclosed in this report any change in the registrant's internal control over
financial reporting that occurred during the registrant's most recent fiscal
quarter (the registrant's fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent functions):

a. all significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

b. any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control over
financial reporting.

Date: October 18, 2004


By:/s/ Payesh Jhaveri
---------------------------------------------------
Payesh Jhaveri
Chief Financial Officer
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JUN-30-1999
<PERIOD-START>                             JUL-01-1998
<PERIOD-END>                               MAR-31-1999
<CASH>                                           4,364
<SECURITIES>                                     6,621
<RECEIVABLES>                                    4,322
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                16,386
<PP&E>                                           6,458
<DEPRECIATION>                                   4,658
<TOTAL-ASSETS>                                  25,280
<CURRENT-LIABILITIES>                            8,003
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            51
<OTHER-SE>                                      17,096
<TOTAL-LIABILITY-AND-EQUITY>                    25,280
<SALES>                                          3,332
<TOTAL-REVENUES>                                 6,254
<CGS>                                              643
<TOTAL-COSTS>                                    1,766
<OTHER-EXPENSES>                                 3,958
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                    660
<INCOME-TAX>                                       244
<INCOME-CONTINUING>                                416
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       416
<EPS-PRIMARY>                                      .08
<EPS-DILUTED>                                      .08
        

</TABLE>
# L_2020054EN.01003401.xml

| 26.2.2020 | EN | Official Journal of the European Union | L 54/34 |
| --- | --- | --- | --- |

26.2.2020

EN

Official Journal of the European Union

L 54/34

---

Corrigendum to Council Decision (EU) 2019/2208 of 9 December 2019 on the position to be taken on behalf of the European Union within the EPA Committee established under the stepping stone Economic Partnership Agreement between Ghana, of the one part, and the European Community and its Member States, of the other part, as regards the adoption of Protocol No 1 concerning the definition of the concept of ‘originating products’ and methods of administrative cooperation

(
  Official Journal of the European Union L 332 of 23 December 2019
  )

On page 139, Annex IV to Protocol No 1 of the draft Decision No .../2019 of the EPA Committee established by the stepping stone Economic Partnership Agreement between Ghana, of the one part, and the European Community and its Member States, of the other, of ... 2019 on the adoption of Protocol No 1 concerning the definition of the concept of ‘originating products’ and methods of administrative cooperation:

for:

‘Croatian version

Izvoznik proizvoda obuhvaćenih ovom ispravom (carinsko ovlaštenje br. ... (1)) izjavljuje da su, osim ako je drukčije izričito navedeno, ovi proizvodi ... (2) povlaštenog podrijetla.’,

read:

‘Croatian version

Izvoznik proizvoda obuhvaćenih ovom ispravom (carinsko ovlaštenje br. ... (1)) izjavljuje da su, osim ako je drukčije izričito navedeno, ovi proizvodi ... (2) preferencijalnog podrijetla.’.

---
I 

118TH CONGRESS 

2D SESSION H. R. 7366 

To require timely publication of CBP border encounters, and for other 

purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 15, 2024 

Mrs. BICE (for herself, Mr. CRENSHAW, Mr. WALBERG, Mr. BAIRD, Mr. 

ROSE, Ms. FOXX, Mr. FLEISCHMANN, Mr. FULCHER, Mr. MOYLAN, Mr. 

WALTZ, Mr. SMITH of Nebraska, Mr. YAKYM, Mr. RUTHERFORD, Mr. 

MCCORMICK, Mr. NEHLS, Mrs. HOUCHIN, Mr. LAWLER, Mr. ARMSTRONG, Mr. BIGGS, Mr. BEAN of Florida, Mr. COLE, Mr. BABIN, and 

Mr. POSEY) introduced the following bill; which was referred to the Committee on Homeland Security 

A BILL 

To require timely publication of CBP border encounters, 

and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. TIMELY PUBLICATION OF CBP BORDER EN4 COUNTERS. 

5 (a) IN GENERAL.—The Secretary of Homeland Secu6 rity, acting through the Commissioner of U.S. Customs 

7 and Border Protection (CBP), shall take such actions as 

8 may be necessary to ensure the timely publication on the 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7366 IH

1 CBP Public Data Portal (or any similar successor such 

2 portal) by not later than the seventh day of each calendar 

3 month of CBP border encounters during the immediately 

4 preceding calendar month. 

5 (b) PROHIBITION.—Federal funds made available for 

6 the salaries and expenses of the Office of the Secretary 

7 of Homeland Security shall be reduced by 25 percent for 

8 the month following any period during which CBP border 

9 encounters are not timely published on the CBP Public 

10 Data Portal (or any similar successor such portal) in ac11 cordance with subsection (a). 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
NOS. 07-11-00413-CR AND 07-11-00414-CR

IN THE COURT OF APPEALS

FOR THE SEVENTH DISTRICT OF TEXAS

AT AMARILLO

PANEL D

APRIL 10, 2012

BRANDON MICHAEL-RAY BENSON, APPELLANT

v.

THE STATE OF TEXAS, APPELLEE

FROM THE 52ND DISTRICT COURT OF CORYELL COUNTY;

NO. FAM-11-20729, FAM-11-20730; HONOR ABLE TRENT D. FARRELL, JUDGE

Before QUINN, C.J., and CAMPBELL and PIRTLE, JJ.

MEMORANDUM OPINION

Pending before the court is the motion of appellant Brandon Be nson to dismiss

his two appeals. Appellant and his attorney have both signed the motion. Tex. R. App.

P. 42.2(a). No decision of th is court having been delivered to date, we grant the motion.

Accordingly, the two appeals are dismiss ed. No motions for rehearing will be

entertained and our mandates will issue forthwith.

James T. Campbell Justice

Do not publish.
NOTE: This disposition is nonprecedential.

United States Court of Appeals 

for the Federal Circuit ______________________ 

DAVID KERMES,

Petitioner

v.

DEPARTMENT OF HOMELAND SECURITY,

Respondent

______________________ 

2015-3148

______________________ 

Petition for review of an arbitrator's decision by Edna 

E.J. Francis.

______________________ 

JUDGMENT

______________________ 

JIM CALLE, Law Office of Jim E. Calle, P.C., Tucson, 

AZ, argued for petitioner.

CHRISTOPHER KEITH WIMBUSH, Commercial Litigation 

Branch, Civil Division, United States Department of 

Justice, Washington, DC, argued for respondent. Also 

represented by BENJAMIN C. MIZER, ROBERT E.

KIRSCHMAN, JR., ALLISON KIDD-MILLER. 

______________________ 

THIS CAUSE having been heard and considered, it is
 

ORDERED and ADJUDGED: 

 PER CURIAM (PROST, Chief Judge, SCHALL and CHEN,

Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

 ENTERED BY ORDER OF THE COURT

 July 14, 2016 /s/ Peter R. Marksteiner 

 Date Peter R. Marksteiner

 Clerk of Court
#### § 26.34 Regulatory authorities.

The regulatory authorities shall have the responsibility of implementing the provisions of this subpart, including the designation and monitoring of conformity assessment bodies (CAB's). Regulatory authorities will be specified in appendix C of this subpart. Each party will promptly notify the other party in writing of any change in the regulatory authority for a country.
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
No. 95-7882
ROY LEE PERRY, II-Bey, Plaintiff - Appellant, and ELLIOTT GAINES, Plaintiff, versus JOHN JABE, Warden; P. A. TERRANGI; D. A. SWETTER, Defendants - Appellees.

No. 96-6446
ELLIOTT GAINES, Plaintiff - Appellant, and ROY LEE PERRY, Plaintiff, versus JOHN JABE, Warden; P. A. TERRANGI; D. A. SWETTER, Defendants - Appellees.23 Appeals from the United States District Court for the Eastern District of Virginia, at Alexandria. Albert V. Bryan, Jr., Senior District Judge. (CA-95-851-AM) Submitted: June 20, 1996 Decided: June 27, 1996 Before HALL, WILKINS, and HAMILTON, Circuit Judges. No. 95-7882 dismissed and No. 96-6446 affirmed by unpublished per curiam opinion. Roy Lee Perry, Elliott Gaines, Appellants Pro Se. Lance Bradford Leggitt, OFFICE OF THE ATTORNEY GENERAL OF VIRGINIA, Richmond, Virginia; David Ernest Boelzner, WRIGHT, ROBINSON, OSTHIMER & TATUM, Richmond, Virginia, for Appellees. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).4 PER CURIAM: Appellants appeal the district court's orders dismissing their 42 U.S.C. § 1983 (1988) complaint. The district court assessed a filing fee in accordance with Evans v. Croom, 650 F.2d 521 (4th Cir. 1981), cert. denied , 454 U.S. 1153 (1982), and dismissed the action as to Roy Lee Perry without prejudice when he failed to comply with the fee order. Finding no abuse of discretion, we deny Perry leave to proceed in forma pauperis and dismiss appeal No. 95- 7882. We deny Perry's motion to appoint counsel. The district court dismissed the action as to Elliott Gaines on the merits. Gaines moved for reconsideration, and the district court denied the motions. Gaines filed a notice of appeal which was only timely to the order denying reconsideration. Because we find upon a review of the record that the district court did not abuse its discretion in denying reconsideration, we affirm appeal No. 96- 6446 on the reasoning of the district court. Gaines v. Jabe , No. CA-95-851-AM (E.D. Va. Jan. 25 & Feb. 8, 1996). We dispense withoral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

No. 95-7882 - DISMISSED No. 96-6446 - AFFIRMED
§ 520.455 Clomipramine. ( a ) Specifications. Each tablet contains 5, 20, 40, or 80 milligrams (mg) clomipramine hydrochloride.
( b ) *Sponsors.* See Nos. 051311 and 086039 in § 510.600(c) of this chapter.
( c ) *Conditions of use* — ( 1 ) *Amount.* 2 to 4 milligrams of clomipramine hydrochloride per kilogram (0.9 to 1.8 milligrams per pound) of body weight per day, administered as a single daily dose or divided twice daily.
( 2 ) *Indications for use.* For use as part of a comprehensive behavioral management program to treat separation anxiety in dogs greater than 6 months of age.
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[64 FR 1762, Jan. 12, 1999, as amended at 72 FR 262, Jan. 4, 2007; 86 FR 57996, Oct. 20, 2021]
Editorial Note on Part 112
Editorial Note: Nomenclature changes to part 112 appear at 81 FR 49896, July 29, 2016.

§ 112.182 What are the permissible types of variances that may be granted? A variance(s) may be requested for one or more requirements in subparts A through O of this part. Examples of permissible types of variances include: ( a ) Variance from the microbial quality criteria when agricultural water is used during growing activities for covered produce (other than sprouts) using a direct water application method, established in § 112.44(b);
( b ) Variance from the microbial die-off rate that is used to determine the time interval between last irrigation and harvest, and/or the accompanying maximum time interval, established in § 112.45(b)(1)(i); and
( c ) Variance from the approach or frequency for testing water used for purposes that are subject to the requirements of § 112.44(b), established in § 112.46(b).
NOAA'S NATIONAL WEATHER SERVICE 

Guide to Hydrologic 

Information on the Web 
National Map 

This web page shows the flood status at all National Weather Service river forecast locations. 

locations currently in 

This web page shows the. 

allow user to move 

Lawrence.? 

n H Kerr Dam 

Lnhe Gastl 

-- - 

~b~gO~Igeb -at... -. nR*wl. J Other Rivers . HI&WYS -..tie 

UHSA %Names .Nab .Names 

' C 

~tensive inundatinof 

rudures and roads. 

~gnificant evacuations 

: people and property. 

liver or stream gauge i 

ot operatino. 
Hydrograph 

is the first graphic displayed after clicking on a specific rivertstream location on the 

provides recent observations and for many points a forecast for the next few days. Tabs at 

the top of the hydrograph allow a %XI display other graphical information for the riverlsteam location. 

there is a 25% chance 

the stage will exceed 

about 9.1 feet and the 

UNUly -4 I lty 

Flwd Uul 18.0 CPd 
Flood Inundation Map 

This interactive web.page shows the spatial extent of possible or expected flooding in a given area. It can be used to 

show if roadways and structures will be impacted by floodwaters. At the limited number of forecast locations where 

inundation maps are currently available, this web page is accessed by clicking on the inundation mapping tab on the 

hydrograph web page. In collaboration with partners, this product will be expanded to new locations. 

Activate feature to show * 

water depth at cursor 

(detailed mode only). 

I 

Set display: inundation 

levels, Rood categories, 

or current forecast. I 

w 

National Weather ~ervftd 

Advanced Hydrologic Prediction 

Home News Organlzat~on Searchtor 0 HWS hll NOAl 

. . .,*. .. :... Neuse Mr near 

Goldsboro. NC (GLDN7) I 

Flood category display 

Clicking 

anywhere on 

] inteyt. I 

is shown on 

overlays 

lnundat~o!~ Lmls 

Flood Categotres * CunenWorecasl 

LuIlm~ 

7.U.. I? meForecaII: " Notwlhm lnundatlo 1 

for FEMA W ;=& 

I Menu for inundation 

levels shown on map: lnundatlon Feedback 

i OD Year Flu00 4 500 'Year Fluud . Floudway Dsta 

- beains. 

Mouse cursor location 

information, including 

water depth when the 

I feature is activated. I 
Precipitation 

This web page shows the digital precipitation estimates used in National Weather Service river forecast model 4 

i 

digital data in shapefile 

cipitation display and its 

Provides list of links to 

other precipitation - 

related web pages. 

current, archived 

monthly, or archived 

depending on archive 

pi.- I".. .i* 

pi=.. my, hallhe I 
The Adv logic Prediction Service, or AHPS, is a prqpm in NOMs National 

:d5. c Weather fks'vke dasigned to provide improved ri.Seradd EW fbnmmting and water in- +* 

, T~N - fomtkm $sLHPS provides a suite of graphical aabd nwneric prdwts over the Internet to 2 - 'assist etmmauniQ 1- and emergency manam in making better life- and cost-saving 

-r+q decisions &out ~wtionsand movement of prop@ bdbe flooding occurs. 

-54 

To access the water information in this kwhtue;, see: 

Feedback on these web pages is welcome at: 

www.weather.gov/feedback.php &-, ,i.- . .. 

NOAAPA 200850
§ 514.121 Service of notices and orders. All notices and orders under this subchapter E and section 512 of the act pertaining to new animal drug applications shall be served: ( a ) In person by any officer or employee of the Department designated by the Commissioner; or
( b ) By mailing the order by certified mail addressed to the applicant or respondent at his last known address in the records of the Food and Drug Administration.
[Federal Register Volume 75, Number 8 (Wednesday, January 13, 2010)]
[Notices]
[Page 1792]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-421]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel, Small 
Research Grants Review.
    Date: February 4, 2010.
    Time: 10 a.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Michael L. Bloom, PhD, MBA, Scientific Review 
Officer, National Institute of Arthritis, Musculoskeletal and Skin 
Diseases, National Institutes of Health, 6701 Democracy Blvd; Room 
820, MSC 4872, Bethesda, MD 20892-4872, 301-594-4953, <a href="/cdn-cgi/l/email-protection#5914303a31383c35061b3536363419373031773e362f"><span class="__cf_email__" data-cfemail="7f32161c171e1a13203d131010123f11161751181009">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS)

    Dated: January 6, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-421 Filed 1-12-10; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
§ 4.3 What current good manufacturing practice requirements apply to my combination product? Cross Reference
Link to an amendment published at 89 FR 51766 , June 18, 2024.
If you manufacture a combination product, the requirements listed in this section apply as follows: ( a ) The current good manufacturing practice requirements in parts 210 and 211 of this chapter apply to a combination product that includes a drug constituent part;
( b ) The current good manufacturing practice requirements in part 820 of this chapter apply to a combination product that includes a device constituent part;
( c ) The current good manufacturing practice requirements among the requirements (including standards) for biological products in parts 600 through 680 of this chapter apply to a combination product that includes a biological product constituent part to which those requirements would apply if that constituent part were not part of a combination product; and
( d ) The current good tissue practice requirements including donor eligibility requirements for HCT/Ps in part 1271 of this chapter apply to a combination product that includes an HCT/P.
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          APR-30-2000
<PERIOD-START>                             MAY-01-1999
<PERIOD-END>                               OCT-31-2000
<CASH>                                          12,413
<SECURITIES>                                    39,729
<RECEIVABLES>                                   12,382
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                66,848
<PP&E>                                          24,061
<DEPRECIATION>                                  17,001
<TOTAL-ASSETS>                                  87,772
<CURRENT-LIABILITIES>                           34,316
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        62,372
<OTHER-SE>                                    (11,540)
<TOTAL-LIABILITY-AND-EQUITY>                    87,772
<SALES>                                         35,725
<TOTAL-REVENUES>                                35,725
<CGS>                                           10,280
<TOTAL-COSTS>                                   61,405
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                               (31,930)
<INCOME-TAX>                                     4,164
<INCOME-CONTINUING>                           (36,094)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (36,094)
<EPS-BASIC>                                   (3.55)
<EPS-DILUTED>                                   (3.55)


</TABLE>